Moderna, Inc.
MRNA
$36.12
$0.511.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.56B | -2.22B | -5.87B | -5.97B | -4.71B |
| Total Depreciation and Amortization | 189.00M | 331.00M | 528.00M | 579.00M | 621.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 446.00M | -576.00M | 925.00M | 614.00M | 286.00M |
| Change in Net Operating Assets | -78.00M | -738.00M | 1.17B | 1.89B | 689.00M |
| Cash from Operations | -3.00B | -3.21B | -3.24B | -2.88B | -3.12B |
| Capital Expenditure | -1.05B | -749.00M | -738.00M | -790.00M | -707.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -85.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00B | 2.70B | 2.76B | 3.10B | 5.00B |
| Cash from Investing | 1.95B | 1.95B | 2.02B | 2.31B | 4.21B |
| Total Debt Issued | 0.00 | 4.00M | 1.00M | -- | -- |
| Total Debt Repaid | -10.00M | -124.00M | -189.00M | -246.00M | -270.00M |
| Issuance of Common Stock | 66.00M | 70.00M | 69.00M | 53.00M | 47.00M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -628.00M | -1.15B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 56.00M | -50.00M | -119.00M | -821.00M | -1.38B |
| Foreign Exchange rate Adjustments | 0.00 | 1.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -999.00M | -1.31B | -1.34B | -1.39B | -289.00M |
